Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
0.00 (0.00%)
Jan 9, 2026, 9:05 AM EST
-92.31%
Market Cap4.59M
Revenue (ttm)10.88K
Net Income (ttm)-2.93M
Shares Out76.57M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,000
Average Volume47,758
Open0.0600
Previous Close0.0600
Day's Range0.0600 - 0.0600
52-Week Range0.0500 - 1.2500
Beta-0.05
RSI28.99
Earnings DateMay 28, 2026

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.